Metabolic Effects of an AT1-receptor Blockade Combined With HCTZ in Cardiac Risk Patients: A Non Interventional Study in Primary Care
BMC Cardiovascular Disorders - United Kingdom
doi 10.1186/1471-2261-8-30
Full Text
Open PDFAbstract
Available in full text
Date
November 10, 2008
Authors
Publisher
Springer Science and Business Media LLC